Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
Trial details
- Registry ID
- NCT04856085
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionNCT04856085 | VIR | Phase 2 | Completed | 2026-03-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |